Publications by authors named "Peter Achenbach"

Claim this Profile
E
Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort.
Jennifer J Couper, Helena Oakey, Megan A S Penno, John M Wentworth, Kelly Watson, Peter Achenbach

Diabetologia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying the Rate of Disease Progression by Progression Likelihood Scores in Children and Adolescents With Stage 1 and Stage 2 Type 1 Diabetes in Germany.
Andreas Weiss, Lenche Chakievska, Peter Achenbach, Maja Hergl, Sandra Hummel

Diabetes Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.
Anette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, Reinhard Berner, Kristina Casteels

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of the Sensitivity, Specificity, Concordance, and 5-Year Predictive Power of Diabetes-Related Autoantibody Assays.
Jeffrey P Krischer, Sarah Muller, Lu You, Peter Achenbach, Elena Bazzigaluppi

Diabetes· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol.
Sandra Hummel, Alexandra Käßl, Stefanie Arnolds, Peter Achenbach, Reinhard Berner

Contemp Clin Trials Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino

Diabetologia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Early Detection Of Type 1 Diabetes By Islet Autoantibody Screening: A Position Paper Of The Fr1daplex Project Leaders And Training Centres, Bvkj Bavaria And Paednetz (Registered) Bavaria].
Peter Achenbach, Reinhard Berner, Ezio Bonifacio, Susanne Brämswig, Sonja Braig

Gesundheitswesen· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Concepts and Success Stories in Type 1 Diabetes Research: A Road Map for a Bright Future.
Roberto Mallone, Emily Sims, Peter Achenbach, Chantal Mathieu, Alberto Pugliese

Diabetes· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents.
Luisa Hoffmann, Mirjam Kohls, Stefanie Arnolds, Peter Achenbach, Regine Bergholdt

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino

Diabetes Care· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset Diabetes.
Sian L Grace, Kathleen M Gillespie, Claire L Williams, Vito Lampasona, Peter Achenbach

Diabetes· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino

Diabetologia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino

Diabetologia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino

Diabetes Care· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care.
Ezio Bonifacio, Christiane Winkler, Peter Achenbach, Anette-Gabriele Ziegler

Lancet Diabetes Endocrinol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers.
Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Martin Kindermans, Frédéric Parmentier

BMC Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays.
Rebecca C Wyatt, Sian L Grace, Cristina Brigatti, Ilaria Marzinotto, Ben T Gillard, Peter Achenbach

Diabetes· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes.
A Emile J Hendriks, M Loredana Marcovecchio, Rachel E J Besser, Ezio Bonifacio, Kristina Casteels, Peter Achenbach

Diabetes Metab Res Rev· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter].
Sandra Hummel, Nadine Friedl, Christiane Winkler, Anette-G Ziegler, Peter Achenbach

Diabetologia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation and clinical outcomes in children and adolescents with diabetes according to newly defined subgroups: a cohort study from the DPV registry.
Katharina Warncke, Alexander Eckert, Ezio Bonifacio, Peter Achenbach, Olga Kordonouri

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation.
Sandra Hummel, Johanna Carl, Nadine Friedl, Christiane Winkler, Kerstin Kick, Peter Achenbach

Diabetologia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
Marija Lugar, Anne Eugster, Peter Achenbach, Thekla von dem Berge, Reinhard Berner

JAMA· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.
Ilaria Marzinotto, David L Pittman, Alistair J K Williams, Anna E Long, Peter Achenbach

Diabetologia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.
Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Mohammad Alhadj Ali, Colin Dayan

BMC Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype.
Sara Puente-Marin, Fabrícia Dietrich, Peter Achenbach, Hugo Barcenilla, Johnny Ludvigsson

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis